Type 2 diabetes mellitus Nutritional, Metabolic, Endocrine Diabetes mellitus type 2
Conditions
Interventions
Intervention programs that successfully improve management of chronic diseases share similar characteristics. First, a framework of explicit care plans (or critical pathways) is used to guide patient
Sponsors
Canadian Diabetes Association
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with type 2 diabetes, who are not considered for urgent assessment by the Regional Diabetes Program (i.e. those with A1c <0.08, blood pressure <220/120, or triglycerides <15 mmol/l)
Exclusion criteria
Exclusion criteria: 1. Subjects currently followed in specialty clinics for management of hypertension, hyperlipidemia, or diabetes 2. Those who decline an invitation to participate 3. Those who are cognitively impaired (i.e. unable to give informed consent) 3. Those who are not responsible for their own medication consumption 4. Those who are unable to communicate in English
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of subjects achieving a 10% reduction in systolic blood pressure from baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Outcome-based variables: 1. Differences in systolic blood pressure (BP) changes between groups 2. Proportion of subjects achieving the BP target of <130/80 3. Differences in A1c changes between groups 4. Differences in low-density lipoprotein (LDL) changes between groups 5. Difference in 10-year risk of cardiovascular disease as calculated by: 5.1. Framingham risk score 5.2. United Kingdom Prospective Diabetes Study (UKPDS) risk equation Process-based variables, adjustment in drug therapy 6. Initiate regular aspirin use for cardiovascular disease prevention 7. Initiate angiotension-converting enzyme (ACE) inhibitor therapy for vascular protection 8. Change to antihypertensive therapy 9. Change to lipid-lowering drug therapy 10. Difference in adherence rate to antihypertensive drug therapy between groups 11. Difference in proportions of subjects having Canadian Diabetes Association guideline-based recommendations in past year 12. Measurement of A1c (outside of protocol-driven measure at study end) 13. Measurement of fasting lipid profile (outside of protocol-driven measure at study end) 14. Measurement of creatinine ratio (ACR) 15. Measurement of urinary albumin 16. Eye examination for retinopathy 17. Foot examination by a health care professional | — |
Countries
Canada
Outcome results
None listed